InTech uses cookies to offer you the best online experience. By continuing to use our site, you agree to our Privacy Policy.

Medicine » Mental and Behavioural Disorders and Diseases of the Nervous System » "Autism Spectrum Disorders: The Role of Genetics in Diagnosis and Treatment", book edited by Stephen Deutsch, ISBN 978-953-307-495-5, Published: August 1, 2011 under CC BY-NC-SA 3.0 license. © The Author(s).

Chapter 6

The Genetic Basis of Phenotypic Diversity: Autism as an Extreme Tail of a Complex Dimensional Trait

By Shinji Ijichi, Naomi Ijichi, Yukina Ijichi, Hisami Sameshima and Hirofumi Morioka
DOI: 10.5772/19032

Article top

Overview

Cellular and molecular interactions of biological noise in regulatory networks around a gene locus (A). Additive and/or non-additive phenomena can be involved in each interaction (Ijichi et al., 2011). In this explanation, an arrow represents the net contribution between loci and the gene-environment relationship. The locus A can interact with other loci in association with coding RNA and/or non-coding RNA level in cis-acting manner (①, ②) and trans-acting manner (③, ④). The cis-acting interactions are involved in genetic imprinting. After translation, interactions can be mediated through autocrine, paracrine, and endocrine mechanisms (⑤, ⑥). Gene-environment interactions can modify penetrance of the outcomes affected by the locus A. The network constituents can change the sensitivity to environmental influences (⑦), that can provide gene-environment-gene circuits. In the monomorphic loci theory, the gene A can be monomorphic and the link between monomorphic A and the A-associated polymorphic noise is usually invisible in the context of traditional genetics.
Figure 1. Cellular and molecular interactions of biological noise in regulatory networks around a gene locus (A). Additive and/or non-additive phenomena can be involved in each interaction (Ijichi et al., 2011). In this explanation, an arrow represents the net contribution between loci and the gene-environment relationship. The locus A can interact with other loci in association with coding RNA and/or non-coding RNA level in cis-acting manner (①, ②) and trans-acting manner (③, ④). The cis-acting interactions are involved in genetic imprinting. After translation, interactions can be mediated through autocrine, paracrine, and endocrine mechanisms (⑤, ⑥). Gene-environment interactions can modify penetrance of the outcomes affected by the locus A. The network constituents can change the sensitivity to environmental influences (⑦), that can provide gene-environment-gene circuits. In the monomorphic loci theory, the gene A can be monomorphic and the link between monomorphic A and the A-associated polymorphic noise is usually invisible in the context of traditional genetics.

The Genetic Basis of Phenotypic Diversity: Autism as an Extreme Tail ofa Complex Dimensional Trait

Shinji Ijichi11, Naomi Ijichi21, Yukina Ijichi21, Hisami Sameshima11 and Hirofumi Morioka11

1. Introduction

Autism is a developmental lifelong condition of the human brain, and a behavioral characterization as a spectrum (autism spectrum disorder: ASD) is the best way to illustrate this complex trait (Frith, 2001; Rapin, 1997; Wing, 1997). The predominant presence of autistic cases without comorbidity (idiopathic or primary ASD) (Freitag, 2007) clearly means that the biological effects associated with the known concomitant medical conditions (cytogenic abnormalities, fragile X syndrome, tuberous sclerosis, congenital infections, maternal thalidomide use, epilepsy, etc.) cannot be the common prerequisite for ASD at least in the majority of the cases. The presence of a strong genetic contribution is evident from the results of twin studies, which demonstrated that 70-90% of monozygotic twins are concordant for ASD, and the concordance in dizygotic twins and the recurrence rate in the proband’s siblings are both less than 10% (Rapin & Katzman, 1998). A broadening of the criteria of diagnosis leads the monozygotic concordance ratio to more than 90%, but 100% concordance is never obtained (Rapin & Katzman, 1998). Therefore, it is claimed that genetic factors contribute about 90% to ASD with environmental factors contributing no more than 10% (Garber, 2007). Although a flood of genetic information in the field of ASD is continuously growing, even the newest genome-wide molecular studies cannot detect the universal genetic prerequisite for idiopathic cases with ASD, compelling some researchers to speculate that ASD has a huge inter-case heterogeneity of the related gene variants.

Many gene variants, which seem to affect brain development and synaptic functions, have been reported in association with the autistic development (Betancur, 2011; Garber, 2007; Persico & Bourgeron, 2006; Pinto et al., 2010). In families with the candidates for autism gene variants, however, the strict co-segregation, in which the gene variant is found only in individuals with ASD among family members including parents, is still exceptional (Table 1). To explain this fact, the broader distribution of the more primary phenotype or pre-behavioral phenotype (endophenotype) beyond the categorical border is introduced as the speculative solution through this research maze (Viding & Blakemore, 2007). It may be quite difficult to detect and evaluate such endophenotypes because of the configurational or hierarchical structures of human cognitions and behaviors. Even if such speculations were all true, it is too early to conclude that “a single gene variant causes a small percentage of cases with this complex trait” (Garber, 2007; Beaudet, 2007). As clearly demonstrated in the case of human disease-associated mutations found as wild-type alleles in normal chimpanzee (L. Azevedo et al., 2006), a deleted or mutated allele does not necessarily contribute to the disease development. Because evidence consistent with a theory is not proof of that theory (Cannell, 2010), until one could delineate the molecular or biological trajectory underlying autistic development which is quantitatively different from the parents, there is still a huge black box between the de novo variant allele and complex human behaviors in the sporadic cases with idiopathic ASD. The reported gene variants are, at present, nothing but one of the concomitants in a small percentage of cases (5-7%, in Table 1). The possibility that the variantsare mere relative risk factors remains to be elucidated (Jones & Szatmari, 2002). As a general rule, a genetic link does not necessarily imply neurological damage (Simpson,

Variants
PrevalenceReferences
SHANK3 variantsIn ASD families15 / 227 (6.6%)a(Durand et al., 2007)
Co-segregated cases3 / 227 (1.3%)b
In controls5 / 270 (1.9%)a
SHANK3 variantsIn ASD families3 / 400 (0.8%)c(Moessner et al., 2007)
SHANK3 variantsIn ASD individuals34 / 427(8.0%)(Gauthier et al., 2009)
In controls16 / 190 (8.4%)
SHANK3 deletionIn ASD individuals1 / 427 (0.2%)c(Gauthier et al., 2009)
In controls0 / 190
SHANK3 deletionIn ASD individuals2 / 2,195 (0.1%)(Glessner et al., 2009)
In controls2 / 2,519 (0.1%)
SHANK2 de novo deletionIn ASD individuals2 / 996 (0.2%)(Pinto et al., 2010)
In controls0 / 1,287, 0 / 3,677
NLGN3 variantsIn ASD individuals0 / 96(Yan et al., 2005)
NLGN3 duplicationIn ASD individuals1 / 2,195 (0.05%)(Glessner et al., 2009)
In controls0 / 2,519
NLGN4 variantsIn ASD individuals4 / 148 (2.7%)d(Yan et al., 2005)
In controls0 / 336
NRXN1 deletionIn ASD families1 / 1,181 (0.1%)(AGPC, 2007)
NRXN1α variantsIn ASD individuals5 / 116 (4.3%)(Yan et al., 2008)
In controls1 / 192 (0.5%)
NRXN1 deletionIn ASD individuals10 / 2,195 (0.5%)(Glessner et al., 2009)
In controls0 / 2,519
NRXN1 de novo variantsIn ASD families4 / 996 (0.4%)(Pinto et al., 2010)
In controls5 / 1,287 (0.4%)
NRXN1β variantsIn ASD individuals4 / 203 (2.0%)d,e(Feng et al., 2006)
In controls0 / 535
NRXN2β variantsIn ASD individuals0 / 72(Feng et al., 2006)
NRXN3β variantsIn ASD individuals0 / 72(Feng et al., 2006)
CNTN4 deletionIn ASD individuals10 / 2,195 (0.5%)(Glessner et al., 2009)
In controls0 / 2,519
CNTN4 duplicationIn ASD individuals9 / 2,195 (0.4%)c(Glessner et al., 2009)
In controls1 / 2,519 (0.04%)
AUTS2In ASD individuals1 / 2,195 (0.05%)(Glessner et al., 2009)
In controls0 / 2,519
DDX53/PTCHD1 deletionIn ASD cases7 / 996 (0.7%)(Pinto et al., 2010)
(maternally inherited)In controls0 / 1,287, 0 / 3,677
CNVs at 15q11-13In ASD individuals15 / 2,195 (0.7%)f(Glessner et al., 2009)
(UBE3A)In controls0 / 2,519
CNVs at 15q11-13In ASD individuals4 / 522 (0.8%)g(Depienne et al., 2009)
CNVs at 16p11.2In ASD families12 / 751 (1.6%)(Weiss et al., 2008)
In controls5 / 4,234 (0.1%)
In ASD individuals3 / 299 (1.0%)
In controls7 / 18,834 (0.04%)
16p11.2duplicationIn ASD individuals9 / 2,195 (0.4%)c(Glessner et al., 2009)
In controls4 / 2,519 (0.2%)
16p11.2 deletionIn ASD individuals8 / 2,195 (0.4%)h(Glessner et al., 2009)
In controls4 / 2,519 (0.2%)
CNV gain at 1q21In ASD families3 / 1,181 (0.3%)d(AGPC, 2007)
CNV at 17p12In ASD families3 / 1,181 (0.3%)i(AGPC, 2007)
CNV gain at 22q11.2In ASD families2 / 1,181 (0.2%)d(AGPC, 2007)
22q11.2 duplicationIn ASD individuals9 / 2,195 (0.4%)(Glessner et al., 2009)
In controls0 / 2,519
De novo CNVsIn ASD families10 / 1,181 (0.8%)(AGPC, 2007)
Co-segregated cases3 / 1,181 (0.3%)j
De novo CNVsIn ASD individuals14 / 195 (7.2%)k(Sebat et al., 2007)
In sporadic cases12 / 118 (10.2%)
In multiplex families2 / 77 (2.6%) k
In controls2 / 196 (1.0%)
De novo CNVsIn ASD families27 / 427 (6.3%)(Marchall et al., 2008)
In sporadic cases4 / 56 (7.1%)
In multiplex families1 / 49 (2.0%)
De novo CNVsIn ASD families50 / 876 (5.7%)l(Pinto et al., 2010)
In simplex families22 / 393 (5.6%)
In multiplex families19 / 348 (5.5%)

Table 1.

The prevalence of variants in gene regions recently implicated in idiopathic ASDASDs: autism spectrum disorders; NLGN: neuroligin gene; NRXN: neurexin gene; CNTN: contactin gene; AUTS: autism susceptibility candidate gene; CNV: copy number variation; AGPC: the Autism Genome Project Consortium. aTwo nonsynonymous SHANK3 mutations were revealed in 4 ASD families and 2 control individuals. bIn the SHANK3 study, de novo truncating mutations in two families and a chromosomal rearrangement in one family were demonstrated as the strict co-segregated cases whose gene variants were found only in individuals with ASD among family members including parents. cOne de novo case is included. dStrict co-segregation was not shown. eTwo cases with mild facial dysmorphism are included. fTwo de novo cases are included. gThree de novo cases are included. hFive de novo cases are included. iOne case is included as a co-segregated family. jIn ASD families with two or more affected individuals (multiplex families), three de novo CNVs were found in both ASD sibs. kTwo multiplex families whose variant-phenotype co-segregation is not mentioned are included. l>0.6% cases are carrying two or more de novo events.

2003), and high heritability does not vindicate the condition as a diagnostic category (Keller & Miller, 2006). There is as yet no qualitative biological marker including microscopic lesions that can reliably help to categorize a genetically homogeneous autism subtype (Amaral et al., 2008; Moldin et al., 2006; Santangelo & Tsatsanis, 2005; Schmitz & Rezaie, 2008). In this article, the significance of gene variants which have currently been detected in autistic individuals is carefully reconsidered and the outstanding questions are addressed from multidisciplinary points of view. Such an attempt may highlight the importance of the notion that the evolutionally survived trait is the phenotypic diversity itself, in which ASD is included as an extreme tail. In addition, important concepts and mechanisms for the genetic basis of phenotypic diversity are also reviewed.

2. Facts and questions

Although some authorities appreciated the smooth behavioral continuum between individuals with ASD and the non-autistic majority (Frith, 2001; Happé, 1999; Rapin, 1997; Wing, 1997), idiopathic ASD has sometimes been misinterpreted as a qualitative disorder which can be clearly distinguished from normal development. The boundary between individuals with low-functioning ASD and a communicative subtype (Asperger syndrome) has also been misrepresented as to be qualitatively distinct (Simpson, 2003). Even the differentiation between Asperger syndrome and high-functioning ASD could be made with authority (Kamp-Becker et al., 2010). These biased constructions may be attributable to referral bias in general practice or increased probability of clinical ascertainment in individuals with low achievement (Skuse, 2007). Although ASD can still be documented as a categorical entity in clinically ascertained samples (Frazier et al., 2010), the fact that the autistic phenotype extends beyond its formal diagnostic boundaries has underscored the significance of quantitative evaluations (Lamb et al., 2000; Maestrini et al., 2000), and many population studies revealed that ASD including high-functioning subtypes are best characterized as an extreme of some bell-shaped behavioral dimensions that distribute quantitatively (Constantino & Todd, 2000; Constantino & Todd, 2003; Happé et al., 2006; Hoekstra et al., 2007; Posserud et al., 2006; Ronald et al., 2005; Ronald et al., 2006a, 2006b; Skuse et al., 2005). The description ‘qualitative’ in the autism criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM) is removed and Asperger’s disorder (Asperger syndrome) is subsumed into ASD in the draft of DSM-5 (http://www.dsm5.org /Pages/Default.aspx). The three quantitative domains including sociability, communication, and rigid/repetitive behavior correlate modestly to each other in the population (Dworzynski et al., 2007; Ronald et al., 2005, 2006a, 2006b), and the coincidence of these phenotypic extremes is also observed in hyperactive individuals with attention-deficit/hyperactivity disorder (AD/HD) (Hattori et al., 2006; Ijichi & Ijichi, 2007; Reiersen et al., 2007; Ronald et al., 2008). The diagnosis of autism is highly affected by the circumstantial consequence of social adaptability and autistic recognition and behavior sometimes does not become fully manifest until social demands exceed the individual’s limited capacities (the draft of DSM-5). The clinical picture can change with increasing age and in different circumstances (Wing, 1997), and the behavioral plasticity or clinical improvement is evident in supportive circumstances by structured behavioral interventions, mentoring, and/or social involvement with appropriate accommodation (Garcia-Villamisar & Hughes, 2007; Ijichi & Ijichi, 2007; McGovern & Sigman, 2005; Tonge et al., 1994).

The most unique and potentially meaningful property of autistic cognition is savant skill. The estimated prevalence of the cognitive superiority in ASD varies from 10% to surprising numbers (Dawson et al., 2007; Happé, 1999; Rapin & Katzman, 1998). The supposed common ‘high intelligence’ in autistic individuals with low IQ may involve high processing speed, prodigious memory capacities, and heightened primary sensory processing (Boddaert et al., 2005; McCleery et al., 2007; Scheuffgen et al., 2000). These cognitive superiorities are believed to have the same origin as the social difficulties in ASD (Brosius & Kreitman), and the term, ‘autistic savant skills’, is used to describe one of the core cognitive features of ASD (Badcock & Crespi, 2006; Scheuffgen et al., 2000). As a unifying explanation which covers the manifold autistic characteristics, excessive neuronal processing (a hyper-functionality model) is also implicated as opposed to usual hypo-functionality explanations (Markram et al., 2007).

The ratio of sibling recurrence risk to population prevalence is approximately 50 with an overwhelming predominance of sporadic cases, suggesting the multifactorial nature of ASD (AGPC, 2007). The high monozygotic concordance rate in twins and the modest recurrence risk in dizygotic twins and among siblings may also suggest that the genetic architecture for ASD has the same complexity as those for human physical appearances including facial characteristics and brain gray matter volume (Ijichi & Ijichi, 2004). In traditional views, the modest correlation between autistic behavioral domains in population studies implies that there is no single (genetic or endophenotypical) cause for the three autistic extreme characteristics and a mere coincidence of the phenotypic extremes might be the true nature of autistic social difficulties (Happé et al., 2006). Although positive assortative mating might cause phenotypic anticipation and a negative assortative mating between the couple might gather the non-overlapping genetic components in a baby (Ijichi et al., 2008), there is no evidence for such assortative mating (Hoekstra et al., 2007).

As exemplified in Table 1, there is, so far, no universal genetic marker which is co-segregated with ASD in the affected families. In contrast to the early prediction (30-40%) (Beaudet, 2007), no more than 5-7% of ASD cases may be traceable to single or multiple genetic concomitant(s) (Table 1). Although many whole-genome scans for autism susceptibility loci have identified a lot of linkage peaks, the reproduction of the results is exceptional and association studies have failed to identify the gene variants (Sykes & Lamb, 2007). The regions of structural variants including copy number variations (CNVs) seldom conform to the linkage peaks (Sebat, 2007). The lack of an unambiguous pathophysiological marker is also one of the important characteristics of idiopathic autism (Amaral et al., 2008; Moldin et al., 2006; Santangelo & Tsatsanis, 2005; Schmitz & Rezaie, 2008). The only anatomical candidate which can be consistently co-segregated with ASD including masked autistic savants may be a quantitative increase in the number of processing units of cortex (minicolumns) (Casanova, et al., 2002, 2007). The increase in the number of minicolumns is thought to be associated with mammalian brain evolution, and the finding can explain other apparent tendencies revealed in some autistic individuals, including increases in the volume of brain structures and the prevalence of epilepsy (Casanova et al., 2006). Recent preliminary findings suggest that the tendency of brain overgrowth originates prenatally (Hobbs et al., 2007; Leonard et al., 2008). Furthermore, there is no biological deficit including chemical and molecular findings which is universal in individuals with ASD or can reliably help to identify putative subgroups that are genetically homogeneous (Lauritsen & Ewald, 2001). Over-expression of neuron-associated genes is still one of the candidates for molecular markers (Lepagnol-Bestel et al., 2008; Maussion et al., 2008; Rinaldi et al., 2007).

The scientific puzzle, which is metaphorically described as “myopic investigators are still patting the elephant” (Rapin, 1999) remains to be solved (Baron, 2008). Why is the male to female ratio biased (3-4 to 1)? Why cannot the behavioral uniformity with strong genetic contribution be interpreted by common gene variant alleles? Why is the disparity between monozygotic and dizygotic concordances so large? Why do the autistic behavioral domains correlate modestly? Although these questions may provide very important clues and are encouraging researchers to speculate on reasons, the jigsaw is still incomplete. Missing puzzle pieces include the solution of the evolutionary mystery of autism prevalence. Human conditions can be selected and survive when it is somehow associated with increased reproductive success (Nesse & Williams, 1994). However, in spite of the hypo-reproductive tendency of behaviors in extreme cases with ASD (Lord et al., 2000), the estimated high prevalence has never declined (Baird et al., 2006; CDC, 2009; Fombonne, 2009).

3. Genetic and environmental explanations

It is recently recognized that ASD has the highest prevalence (more than 0.5%) in childhood neurodevelopmental conditions (CDC, 2009; Fombonne, 2009). In traditional frameworks, in which researchers are searching the human genome for the condition-specific genetic variants, three genetic models should be considered as the genetic mechanism for such a common phenotypic condition (Gibson, 2009). The quite low effect size of each ASD-related variant is suggested to be the cause of difficulty in replication of the positive findings in the common disease-common variant (CD-CV) model (Anney, 2010). Although a rare alleles of major effect (RAME) model is one of the core principles for recent genome-wide association studies in ASD (Gibson, 2009), the replication may also be complicated by chance findings, as well as differences in ascertainment, because of the modest relative risk of the rare alleles (Anney, 2010). The third model, the infinitesimal model, can make an excuse for the situation of genetic studies, because it is very hard to identify rare variants of small effect by genetic means (Manolio et al., 2009). It is, anyhow, clear that it’s time to reconsider and question simple intuitive models that link a human complex condition to mutation (Gibson, 2009).

3.1. Genetic factors

The non-universality of the candidate gene variants which have previously been implicated in ASD may be consistent with the speculation that heterogeneous sets of gene variants can contribute to ASD (Betancur, 2011; Beaudet, 2007; Garber, 2007). Furthermore, in order to explain the modest correlations between the three autistic behavioral domains, the presence of domain-specific heterogeneous sets of gene variants are also suggested (Happé et al., 2006). However, even novel genetic means including whole genome screening using microarray-based hybridization cannot fully confirm these speculations (Table 1). The frequent absence of diagnostic history of ASD in the parents of an idiopathic ASD proband may suggest that the supposed variants should be carried by a non-ASD parent (incomplete penetrance) or the proband should have de novo mutations (Beaudet, 2007; Constantino & Todd, 2005; Zhao et al., 2007) (Table 2). However again, such genetic transmission is still one of the hypotheses and the concomitant de novo variants can be detected only in a minor part of the cases (Table 1). The number of candidate gene regions is still increasing without a convincing and comprehensive demonstration of the link between such variants and autistic developmental trajectory (Glessner et al., 2009).

The genetic contribution to a quantitative trait may be attributable to the cumulative effect of a set of quantitative trait loci (QTLs) (Plomin et al., 1994, 2009; Plomin & Kosslyn, 2001). Each QTL is neither necessary nor sufficient for the overall phenotypic outcomes, the effect size of each QTL may fluctuate according to other genetic backgrounds (epistasis, non-additive gene-gene interactions) and the environment (gene-environment interactions), and a QTL may affect more than one phenotypic trait (pleiotropy). The concept of epistasis had initially been introduced for ASD as an alternative explanation of the incomplete penetrance or as a risk factor model (Bradford et al., 2001; Folstein & Rosen-Sheidley, 2001; Jones & Szatmari, 2002). Because natural chromosomal and segmental shuffling during normal meiosis is a strong random modifier of epstatic effects among QTLs in a sib-pair and dizygotic twins, the big disparity between monozygotic and dizygotic concordances in autism may be explained by the presence of epistatic QTLs. Pleiotropy can account for the presence of autistic savants. The modest correlation among autistic behavioral domains can also illustrated by unsynchronized epistatic pleiotropy (Ijichi et al., 2008). To explain the sporadic manner of the prevalence and the survival of hypo-reproductive autistic extremes, the implication of epistasis-associated intergenerational oscillation of phenotypic outcomes was introduced (Ijichi et al., 2008). Some candidates for autism QTLs have been reported (Ashley-Koch et al., 2006; Coutinho et al., 2007; Jiang et al., 2004; Weiss et al., 2007), linkage analysis with quantitative measures of some autistic characteristics revealed QTL signals (Alarcón et al., 2002, 2005; Chen et al., 2006; Duvall et al., 2007), and a quantitative covariance analysis can confirm the high genetic correlation between ‘social motivation’ and ‘range of interest/flexibility’ (Sung et al., 2005). Although the supposed contribution of QTLs ought to be traced in family studies or genome scans according to a traditional logic, “the causal gene variant can be cosegregated with the phenotypic variant”, the delay and difficulty in detecting the causal variant alleles at QTLs is strangely common to all idiopathic quantitative traits including autism, physical and physiological characteristics, and personalities (de Geus et al., 2001; Fullerton, 2006; Palmert & Hirschhorn, 2003; Willis-Owen & Flint, 2006).

Facts and questionsExplanations
PenetranceDe novoQTLsEnvironment
The quantitative feature(○)(○)
Partial behavioral plasticity
The presence of autistic savants(○)
Strong genetic contribution
Usually sporadic without family history(○)(○)
Domain-specific genetic factors(○)
Lack of the common genetic marker
Lack of the common pathological lesion
Lack of the common chemical marker
Lack of the common molecular marker
Why is the male to female ratio biased?(○)(○)(○)(○)
Why is it so difficult to detect autism genes?
Why do hypo-reproductive extremes survive?(○)

Table 2.

Genetic and environmental explanations for the facts and outstanding questions in idiopathic autism researchesPenetrance: Poor penetrance of heterogeneous gene variants; De novo: De novo involvement of heterogeneous gene variants; QTLs: Quantitative trait loci; Environment: Environmental contribution; ○: explainable; (○): unexplainable by itself but explainable with some further speculation; -: hard to explain

3.2. Epigenetic factors and ASD

Phenotypic outcomes with robustness or plasticity cannot be exclusively determined by the DNA sequence itself which looks like the core genetic factor of the phenotype (Goldberg et al., 2007). Epigenetics is the study of changes in gene expression that occur without a change in DNA sequence and the epigenotype is meiotically and mitotically transmissible (Morris, 2005; van Vliet et al., 2007). Although the significance of the contribution made by epigenetic factors to human complex traits remains unclear, it is speculated that epigenetic factors can influence gene-environment interactions and the liability/outcomes of the traits (van Vliet et al., 2007). Epigenetic changes in gene expression are achieved through RNA-associated silencing, DNA methylation, and histone modifications (Morris, 2005), and cis-acting expansion of the epigenetic influences on the flanking genes is referred to as genomic imprinting which results in parent of origin-specific gene expression (Pauler et al., 2007). The epigenetic factors and genomic imprinting may be implicated in syndromic autistic individuals with some single gene/chromosomal disorders including Rett syndrome, fragile X syndrome, Prader-Willi syndrome, and Angelman syndrome, and a variety of factors associated with epigenetic modifications have been considered as candidates for autism genes (Badcock & Crespi, 2006; Jiang et al., 2004; Persico & Bourgeron, 2006; Schanen, 2006; Skuse, 2000; van Vliet et al., 2007). These factors, however, cannot be the common prerequisite for idiopathic ASD at least in the majority of the cases (Jiang et al., 2004; Persico & Bourgeron, 2006), and the power of epigenetic factors are recognized as an accidental cue to shift the quantitative distribution of the autistic traits in a threshold model (Skuse, 2000). If the epigenetic factors act only in gene-environment interactions in idiopathic cases, the epigenetic contribution should be modest in the overall underpinnings. Given an unforeseen transmissible powerful architecture connecting genotype and phenotype for phenotypic diversity independent of genetic diversity, the epigenetic mechanism should be referred to as merely one of the molecular-level environments derived from gene networks.

3.3. Environmental factors

Environmental factors contribute no more than 10% to ASD (Garber, 2007). However, the environmental factors including rubella, thalidomide, and valproic acid embryopathies may still be important as additive triggers of the clinical manifestation (Jones & Szatmari, 2002; Persico & Bourgeron, 2006). Environmental contributions including behavioral experiences are originally misunderstood to explain the patterns of familial recurrence risks observed in autism studies (Jorde et al., 1991). Because the genetic components affecting autistic traits seem to be the same across the sexes (Constantino & Todd; Hoekstra et al., 2007), it can be speculated that the lower prevalence of autistic traits in girls is the result of increased sensitivity to early environmental influences that operate to promote social competency (Constantino & Todd, 2003). The minimal contribution of shared environmental influences (Ronald et al., 2006a) may be associated with the autistic behavioral manifestations including resistance to change or insistence on sameness.

Combinations of the traditional theories (poor penetrance, de novo mutations, and QTLs and the environmental contribution) may answer not a few of the outstanding questions in idiopathic autism research (Table 2). However, in spite of the presence of a big genetic contribution to the autistic development, the question, “Why is it difficult to detect autism gene variants?”, still remains to be resolved. In addition, the significance of both de novo mutations and the environmental modification is just a speculation in a part of the ASD cases.

4. Evolutionary explanations

Does idiopathic ASD really represent many distinct conditions with numerous etiologies (Geschwind, 2007)? Is it really time to give up on a single explanation for autism (Baron, 2008; Happé et al., 2006)? A variety of qualitative concomitants, including gene variants and environmental factors, have already been demonstrated in part of autistic cases as exemplified above. However, it may be still too early to reach the conclusion even in such frameworks, because no single qualitative process associated with the concomitants can indicate the molecular or chemical differences between the autistic developmental extremes and the non-autistic majority. In order to understand human complex traits, genetic, molecular, and biochemical explanations should be combined with evolutionary explanations (Nesse & Williams, 1994). In autistic individuals, ASD per se does not shorten the span of life (Gillberg et al., 2010). Although high or preserved androgenic competence is suspected in ASD (Tordjman et al., 1997), the extreme cases almost never marry (Lord et al., 2000). The hypo-fertility results from reduced opportunity or behavioral ability in the mating arena. Therefore, we must probe into who is enjoying the reproductive benefits of the genetic architecture for ASD in the evolutionary framework (Table 3).

Who gets the reproductive benefits?Hypotheses or mechanismsReferences
None (an inevitable outcome)Mutation-selection balance theory(Keller & Miller, 2006)
Unaffected carriers of genetic factorsHyper-systemizing theory (extreme male brain theory)
Extreme imprinted brain theory
(Baron-Cohen, 2002)

(Badcock & Crespi, 2006)
All of the non-autistic majorityPopulation benefit theory
Monomorphic loci theory
(Fitzgerald, 2002)
(Ijichi et al., 2011)

Table 3.

Evolutionary explanations for the survival of autistic extremeness

4.1. Mutation-selection balance theory

In the mutation-selection balance theory, individuals with a high load of mutations are postulated to be at higher chance of passing risk on to their offspring, and it is not necessary that there are individuals with the reproductive benefits (Keller & Miller, 2006). Importantly, according to the proposed model, everyone alive has minor brain deviations that cause them to be a little bit abnormal in behavioral and cognitive dimensions (Keller & Miller, 2006). The non-autistic majority in the population is regarded as the genetic carrier-state for ASD and the mutation load and the risk of having autistic offspring may vary quantitatively. In the mutation-selection balance theory, balancing selection for genetic diversity is recognized to be unsuitable to explain persistent heritability in human conditions (Keller & Miller, 2006; Zhang & Hill, 2005). One of the grounds of this exclusion of balancing selection is the absence of an ongoing homeostatic mechanism that counteracts the homogenizing effect of genetic drift and stabilizing selection, and the reproductive benefits of the genetic burden for autism are not addressed (Keller & Miller, 2006). The mutation-selection perspective can be an evolutionary interpretation of a cumulative effect of de novo mutations and is at least consistent with the quantitative distribution of autistic domains.

4.2. Extreme male brain theory

The second is a group of theories in which only a part of the population is regarded as the genetic carrier-state for ASD. The prevalence or maintenance of positive assortative mating between the non-autistic carriers is critical to accumulate genetic factors in these theories, and the remaining non-autistic majority does not have the genetic components for ASD. In the hyper-systemizing theory, the unaffected carriers of the genetic factors are high systemizers and ASD is the result of both parents being the high systemizers (Baron-Cohen, 2002, 2004, 2006). Systemizing is the drive to understand and predict the next step of inanimate events and acts contrary to empathizing. In males, the systemizing mechanism is set at a slightly higher level than non-autistic males (Baron-Cohen, 2004). This extreme male brain theory of autism had originally been proposed by Asperger in 1944. Individuals including both parents of individuals with autism, who are placed in the adjacent part to the autistic extremeness, systemize at a higher level than average (above average systemizers) and account for approximately a half of the vast majority. Over successive generations, the above average systemizers carry the genetic components for ASD and might enjoy the reproductive benefits. As one of the genetic bases of the hyper-systemizing theory, the extreme imprinted brain theory had been proposed (Badcock & Crespi, 2006).

4.3. Population benefit theory and individual benefit theory

In the third framework, it is suggested that the evolutionarilly selected and conserved phenotype is not the hypo-reproductive extremeness but the whole quantitative distribution itself. A group selection theory has been introduced to bring sense into the link between autism and exceptional creativity (Fitzgerald, 2003). In this population benefit theory, the creativity, which can be concomitant with autism, benefits all members of the human community and the community can survive. On the other hand, the third framework can also include individual benefit concepts (the monomorphic loci theory) (Ijichi et al., 2011). In the individual benefit concepts, everybody has both the genetic architecture for ASD and the possibility to enjoy the reproductive benefits of autism genes. Each phenotypic outcome, however, varies individually mainly according to the differences in genetic background noise and environmental factors, whose functions are not necessarily related to ASD phenotypes directly. In the process of reaching the monomorphic loci theory, the epistasis-mediated intergenerational oscillation of phenotypic outcomes has been advanced in a QTL model (Ijichi et al., 2008). The monomorphic loci theory does not dismiss the comprehensive view of the known genetic contributions, including major gene effects and additive genetic networks (Ijichi et al., 2011). The postulated involvement of monomorphic loci can be valid as merely one of the genetic constituents in complex (additive and/or non-additive) interactions with polymorphic loci.

4.4. The monomorphic loci theory and gene networks

Because both positive and negative epistasis may be byproducts of evolution (L. Azevedo et al., 2006; R.B.R. Azevedo et al., 2006; Harrison et al., 2007), the invisibility of the contribution of monomorphic epistatic loci from the traditional genetic view is an attractive candidate for the explanation of the black box between polymorphic genotype and phenotypic diversity (Ijichi et al., 2011). Complex phenotypes have hierarchical structures, including RNA (transcript traits), protein, metabolite, and functional levels. It has been suggested that less heritability of metabolite traits than transcript traits is associated with the difference in the quantity of biological noise between the genetic determinants and the trait (Rowe et al., 2008). The more steps that are involved between genotype and the trait level, the more biological noise may reside in the process. Such biological noise originates from inter-locus interactions and gene-environment interactions, and the inter-locus interactions may have an important role in the biological noise. Additive and/or non-additive inter-locus interactions with other loci are available in a variety of processes including cis-, trans-, and inter-cellular interactions (Figure 1). The presence of gene-environment-gene circuits may make it difficult to distinguish inter-locus interactions from gene-environment interactions in the biological noise (Ijichi et al., 2011). In these interactions, an intergenerational change in the number or property of factors (environment and/or other related loci) in the regulatory circuit may easily individualize the balance of each hierarchical trajectory (coding RNA, non-coding RNA, translation, autocrine, paracrine, and endocrine levels) and individually determine the developmental outcomes. The net non-additive effects of the biological noise are metaphorically interpreted as hub-and-spoke structures of regulatory networks among polymorphic loci (Benfey & Mitchell-Olds, 2008).

media/image2.png

Figure 1.

Cellular and molecular interactions of biological noise in regulatory networks around a gene locus (A). Additive and/or non-additive phenomena can be involved in each interaction (Ijichi et al., 2011). In this explanation, an arrow represents the net contribution between loci and the gene-environment relationship. The locus A can interact with other loci in association with coding RNA and/or non-coding RNA level in cis-acting manner (①, ②) and trans-acting manner (③, ④). The cis-acting interactions are involved in genetic imprinting. After translation, interactions can be mediated through autocrine, paracrine, and endocrine mechanisms (⑤, ⑥). Gene-environment interactions can modify penetrance of the outcomes affected by the locus A. The network constituents can change the sensitivity to environmental influences (⑦), that can provide gene-environment-gene circuits. In the monomorphic loci theory, the gene A can be monomorphic and the link between monomorphic A and the A-associated polymorphic noise is usually invisible in the context of traditional genetics.

5. Quantitative domains and genetic factors

The distributional shift of a bell-shaped curve and the change in the curve shape illustrates the mean value change and the variance alteration of the quantitative dimension, respectively (Gibson, 2009). These changes can affect the proportion of individuals with autism to those without as determined by a liability threshold. The biased male to female ratio (3-4 to 1) in ASD is plausibly interpreted as a distributional shift of the quantitative bell-shaped curve as a gender gap. In the hyper-systemizing theory, the male systemizing mechanism is set at a slightly higher level than in females (Baron-Cohen, 2004). In an imprinted-X liability threshold model, actions of some X-linked genes, which are expressed only from paternal X-chromosome, are suggested to be associated with the male predisposition to ASD (Skuse, 2000). The gender is a bimorphic genetic variation and there is a gender gap in sensitivity or vulnerability to environmental factors (Constantino & Todd, 2003). The relationship between a bell-shaped quantitative distribution and the genetic factors underlying the complex phenotype still remains to be elucidated.

5.1. Polygenic liability model

The traditional concept of polygenic liability supposes a normal distribution of frequencies of susceptibility variant alleles (Gibson, 2009). The manner of the allele contribution is additive, and each allele contribution usually results in a positive or negative effect on the phenotype in the carrier individual and the quantitative population dimension results from such additive allele contributions. To explain the smooth normal distribution, an environmental variance of each allele contribution is addressed in this model.

In a genetic model, oligogenicity with epistasis, the contributing genes are likely to be common ones in the population (Folstein & Rosen-Sheidley, 2001). There is no evidence that the genetic causative processes affecting the autistic extreme are different from those contributing the autistic dimension including individuals without autism (Ronald et al., 2006a). If the presence of epistasis, pleiotropy, and gene-environment interactions are all supposed, the polymorphic genetic underpinning is referred to as QTLs (Plomin et al., 1994, 2009; Plomin & Kosslyn, 2001). However, it is also the fact that the delay and difficulty in detecting the causal variant alleles at QTLs is common to all idiopathic quantitative traits including ASD, physical and physiological characteristics, and personalities (de Geus et al., 2001; Fullerton, 2006; Palmert & Hirschhorn, 2003; Willis-Owen & Flint, 2006).

If the genetic factors for a tail of the bell-shaped curve are different from those for the majority and have extremity-specific properties including serious involvement of coding gene segments (Mitchison, 2000), the variant alleles should be more detectable. Because the genetic contribution in ASD is the biggest in human complex traits and the environmental influence on ASD is quite minimal as described above, the difficulty in finding the universal genetic marker for ASD warrants the necessity of a paradigm shift.

5.2. Additive and non-additive interactions between mono- and poly-morphic loci

It has been emphasized that the three behavioral domains of ASD modestly correlate to each other and the set of genes for each domain may be partly different (Dworzynski et al., 2007; Happé et al., 2006; Ronald et al., 2005, 2006a, 2006b). The speculated modest genetic overlap among autistic domains may be indistinguishable from that among human complex phenotypes including ASD, bipolar disorder, and schizophrenia (Rzhetsky et al., 2007), suggesting that the autistic domains and these psychiatric conditions might share the same genetic architecture at least in part (Craddock & Owen, 2010). In an argument about domain-specific genes for cognitive functions, it is expected that the domain-general genes are responsible for the brain infrastructure including receptors, neurotransmitters, dendritic spines, synapse vesicles, and axonal filaments (Marcus & Rabagliati, 2006). Although the universality of the domain-general genes for cognitive functions among other human complex phenotypes is controversial, genes for the brain infrastructure are also current topics in the field of ASD (Garber, 2007; Persico & Bourgeron, 2006). Both the heterogeneity of genetic markers for ASD and the modest correlation among autistic core domains can be explained by epistasis-mediated oscillation of the domain-general effect values and unsynchronized epistatic pleiotropy in the monomorphic loci theory, which never dismiss the comprehensive view of the known genetic contributions, including major gene effects and additive genetic networks (Ijichi et al., 2011). The assumption of the random outcomes mediated by the non-additive interactions between functional monomorphic loci and polymorphic backgrounds may transform the traditional complementary roles of some monomorphic loci (Gjuvsland et al., 2007) to active and leading roles for the phenotypic diversity (Ijichi et al., 2011). However, the controversy concerning the importance of non-additive effects in phenotypic diversity still exists (Gale et al., 2009; Hill et al., 2008; Malmberg & Mauricio, 2005).

5.3. Social environmental changes and decanalization

The decanalization concept may have sizable significance in searching the cause of the maintained or increasing prevalence of ASD. Canalization is an evolutionary phenomenon characterized by robustness to genetic or environmental perturbation, and most individuals tend to cluster around the optimal phenotype in canalized populations (Gibson, 2009). If the phenotypic dimension consists of multiple endophenotypic vectors which have nonlinear relationships to each other and are partially determined by genetic factors, overt environmental perturbations for one of the endophenotypes can be the cue of decanalization, which changes the shape of the phenotypic demensional distribution (Gibson, 2009). Social environmental perturbations may also shift the entire distribution of ASD liability, or move the liability threshold.

6. Conclusions

The difficulty in detecting the universal biological marker for the predisposition to ASD presents significant challenges and conflicts to researchers in related fields. The reported gene variants in some sporadic cases with idiopathic ASD are nothing but one of the concomitants, until the molecular or biological trajectory underlying autistic development is clearly delineated or association studies reproduce the causal relationship. Before the speculation that idiopathic ASD represents many distinct conditions with numerous etiologies, the quantitative manner of the distribution of the behavioral domains and the fact that ASD is a mere tail of the behavioral dimensions should strictly be considered and emphasized. Even combinations of traditional theories including poor penetrance, de novo mutations, quantitative trait loci, and environmental contribution cannot fully account for the entire genetic underpinning. Importantly, the almost monolithic insight into the prevalence of ASD can only be obtained in an evolutionary framework on the assumption that the complex genetic networks are responsible not for the individual cases but for the human behavioral diversity itself. Gender differences, environmental factors, epigenetic mechanisms including genetic imprinting, and major gene effects may all be mere accidental modifiers of the relationship between the diversity and the liability threshold.

Acknowledgements

The authors greatly thank Professor Bryan H. King for his helpful suggestions.

References

1 - M. Alarcón, R. M. Cantor, J. Liu, T. C. Gilliam, Autism. the, Resource. Genetic, Consortium. Exchange, D. H. Geschwind, 2002 Evidence for a language quantitative trait locus on chromosome 7q in multiplex autism families. Am J Hum Genet, 70 6071
2 - M. Alarcón, A. L. Yonan, T. C. Gilliam, R. M. Cantor, D. H. Geschwind, 2005 Quantitative genome scan and ordered-subsets analysis of autism endophenotypes support language QTLs. Mol Psychiatry, 10 747757
3 - D. G. Amaral, C. M. Schumann, C. W. Nordahl, 2008 Neuroanatomy of autism. Trends Neurosci, 31 137145
4 - R. Anney, L. Klei, D. Pinto, R. Regan, J. Conroy, T. R. Magalhaes, et al. 2010 A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet, 19 40724082
5 - A. E. Ashley-Koch, H. Mei, J. Jaworski, Ma D. Q. , M. D. Ritchie, M. M. Menold, et al. 2006 An analysis paradigm for investigating multi-locus effects in complex disease: examination of three GABAA receptor subunit genes on 15q11-q13 as risk factors for autistic disorder. Ann Hum Genet, 70 281292
6 - Genome. Autism, Consortium. Project, P. Szatmari, A. D. Paterson, L. Zwaigenbaum, W. Roberts, J. Brian, X. Q. Liu, et al. 2007 Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet, 39 319328
7 - L. Azevedo, G. Suriano, B. van Asch, R. M. Harding, A. Amorim, 2006 Epistatic interactions: how strong in disease and evolution? Trends Genet, 22 581585
8 - R. B. R. Azevedo, R. Lohaus, S. Srinivasan, K. K. Dang, C. L. Burch, 2006 Sexual reproduction selects for robustness and negative epistasis in artificial gene networks. Nature, 440 8790
9 - C. Badcock, B. Crespi, 2006 Imbalanced genomic imprinting in brain development: an evolutionary basis for the aethiology of autism. J Evol Biol, 19 10071032
10 - G. Baird, E. Simonoff, A. Pickles, S. Chandler, T. Loucas, D. Meldrum, et al. 2006 Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the special needs and autism project (SNAP). Lancet, 368 210215
11 - I. S. Baron, 2008 Autism spectrum disorder: complex, controversial, and confounding. Neuropsychol Rev, 18 271272
12 - S. Baron-Cohen, 2002 The extreme male brain theory of autism. Trends Cogn Sci, 6 248254
13 - S. Baron-Cohen, 2004 The cognitive neuroscience of autism. J Neurol Neurosurg Psychiatry, 75 945948
14 - S. Baron-Cohen, 2006 The hyper-systemizing, assortative mating theory of autism. Progr Neuropsychopharmacol Biol Psychiatry, 30 865872
15 - A. L. Beaudet, 2007 Autism: highly heritable but not inherited. Nat Med, 13 534536
16 - P. N. Benfey, T. Mitchell-Olds, 2008 From genotype to phenotype: systems biology meets natural variation. Science, 320 495497
17 - C. Betancur, 2011 Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res, 1380 4277
18 - N. Boddaert, C. Barthélémy, J. B. Poline, Y. Samson, F. Brunelle, M. Zilbovicius, 2005 Autism: functional brain mapping of exceptional calender capacity. Br J Psychiatry, 187 8386
19 - Y. Bradford, J. Haines, H. Hutcheson, M. Gardiner, T. Braun, V. Sheffield, et al. 2001 Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet, 105 539547
20 - J. Brosius, M. Kreitman, 2000 Eugenics: evolutionary nonsense? Nat Genet, 25, 253
21 - J. J. Cannell, 2010 On the aetiology of autism. Acta Paediatrica, 99 11281130
22 - M. F. Casanova, D. P. Buxhoeveden, A. E. Switala, E. Roy, 2002 Neuronal density and architecture (gray level index) in the brains of autistic patients. J Child Neurol, 17 515521
23 - M. F. Casanova, I. A. J. van Kooten, A. E. Seitala, H. van Engeland, H. Heinsen, H. W. Steinbusch, et al. 2006 Minicolumnar abnormalities in autism. Acta Neuropathol, 112 287303
24 - M. F. Casanova, A. E. Awitala, J. Trippe, M. Fitzgerald, 2007 Comparative minicolumnar morphometry of three distinguished scientists. Autism, 11 557569
25 - CDC. 2009 Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators. Prevalence of autism spectrum disorders: Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ, 58 120
26 - G. K. Chen, N. Kono, D. H. Geschwind, R. M. Cantor, 2006 Quantitative trait locus analysis of nonverval communication in autism spectrum disorder. Mol Psychiatry, 11 214220
27 - J. N. Constantino, R. D. Todd, 2000 Genetic structure of reciprocal social behavior. Am J Psychiatry, 157 20432045
28 - J. N. Constantino, R. D. Todd, 2003 Autistic traits in the general population: a twin study. Arch Gen Psychiatry, 60 524530
29 - J. N. Constantino, R. D. Todd, 2005 Intergenerational transmission of subthreshold autistic traits in the general population. Biol Psychiatry, 57 655660
30 - A. M. Coutinho, I. Sousa, M. Martins, C. Correia, T. Morgadinho, C. Bento, et al. 2007 Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet, 121 243256
31 - N. Craddock, M. J. Owen, 2010 The Kraepelinian dichotomy- going, going…but still not gone. Br J Psychiatry, 196 9295
32 - M. Dawson, I. Soulières, M. A. Gernsbacher, L. Mottron, 2007 The level and nature of autistic intelligence. Psychol Sci, 18 657662
33 - E. J. de Geus, M. J. Wright, N. G. Martin, D. I. Boomsma, 2001 Genetics of brain function and cognition. Behav Genet, 6 489495
34 - C. Depienne, D. Moreno-Luca De, D. Heron, D. Bouteiller, A. Gennetier, R. Delorme, et al. 2009 Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry, 66 349359
35 - C. M. Durand, C. Betancur, T. M. Boeckers, J. Bockmann, P. Chaste, F. Fauchereau, et al. 2007 Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet, 39 2527
36 - J. A. Duvall, A. Lu, R. M. Cantor, R. D. Todd, J. N. Constantino, D. H. Geschwind, 2007 A quantitative trait locus analysis of social responsiveness in multiplex autism families. Am J Psychiatry, 164 656662
37 - K. Dworzynski, A. Ronald, M. Hayiou-Thomas, F. Rijsdijk, F. Happé, P. F. Bolton, et al. 2007 Aetiological relationship between language performance and autistic-like traits in childhood: a twin study. Int J Lang Commun Disord, 42 273292
38 - J. Feng, R. Schroer, J. Yan, W. Song, C. Yang, A. Bockholt, et al. 2006 High frequency of neurexin 1β signal peptide structural variants in patients with autism. Neurosci Lett, 409 1013
39 - M. Fitzgerald, 2003 Autism and creativity: is there a link between autism in men and exceptional ability?, Brunner-Routledge, 978-1-58391-213-3 Hove and New York
40 - S. E. Folstein, B. Rosen-Sheidley, 2001 Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet, 2 943955
41 - E. Fombonne, 2009 Epidemiology of pervasive developmental disorders. Pediatr Res, 65 591598
42 - T. W. Frazier, E. A. Youngstrom, L. Sinclair, C. S. Kubu, P. Law, A. Rezai, et al. 2010 Autism spectrum disorders as a qualitatively distinct category from typical behavior in a large, clinically ascertained sample. Assessment, 17 308320
43 - C. M. Freitag, 2007 The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry, 12 222
44 - U. Frith, 2001 Mind blindness and the brain in autism. Neuron, 32 969979
45 - J. Fullerton, 2006 New approaches to the genetic analysis of neuroticism and anxiety. Behav Genet, 36 147161
46 - G. D. Gale, R. D. Yazdi, A. H. Khan, A. J. Lusis, R. C. Davis, D. J. Smith, 2009 A genome-wide panel of congenic mice reveals widespread epistasis of behavior quantitative trait loci. Mol Psychiatry, 14 631645
47 - K. Garber, 2007 Autism’s cause may reside in abnormalities at the synapse. Science, 317 190191
48 - D. Garcia-Villamisar, C. Hughes, 2007 Supported employment improves cognitive performance in adults with autism. J Intellect Disabil Res, 51(Pt 2), 142 EOF150 EOF -150
49 - J. Gauthier, D. Spiegelman, A. Piton, R. G. Lafrenière, S. Laurent, J. St-Onge, et al. 2009 Novel de novo SHANK3 mutation in autistic patients. Am J Med Genet B Neuropsychiatr Genet, 150B, 421424
50 - D. Geschwind, 2007 Autism: searching for coherence. Biol Psychiatry, 62 929950
51 - G. Gibson, 2009 Decanalization and the origin of complex disease. Nat Rev Genet, 10 134140
52 - C. Gillberg, E. Billstedt, V. Sundh, I. C. Gillberg, 2010 Mortality in autism: a prospective longitudinal community-based study. J Autism Dev Disord, 40 352357
53 - A. B. Gjuvsland, B. J. Hayes, S. W. Omholt, Ö. Carlborg, 2007 Statistical epistasis is a generic feature of gene regulatory networks. Genetics, 175 411420
54 - J. T. Glessner, K. Wang, G. Cai, O. Korvatska, C. E. Kim, S. Wood, et al. 2009 Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature, 459 569573
55 - A. D. Goldberg, C. D. Allis, E. Bernstein, 2007 Epigenetics: a landscape takes shape. Cell, 128 635638
56 - F. Happé, 1999 Autism: cognitive deficit or cognitive style? Trends Cogn Sci, 3 216222
57 - F. Happé, A. Ronald, R. Plomin, 2006 Time to give up on a single explanation for autism. Nat Neurosci, 9 12181220
58 - R. Harrison, B. Papp, C. Pál, S. G. Oliver, D. Delneri, 2007 Plasticity of genetic interactions in metabolic networks of yeast. Proc Natl Acad Sci U S A, 104 23072312
59 - J. Hattori, T. Ogino, K. Abiru, K. Nakano, M. Oka, Y. Ohtsuka, 2006 Are pervasive developmental disorders and attention-deficit/hyperactivity disorder distinct disorders? Brain Dev, 28 371374
60 - W. G. Hill, M. E. Goddard, P. M. Visscher, 2008 Data and theory point to mainly additive genetic variance for complex traits. Plos Genetics, 4, e1000008 EOF
61 - K. Hobbs, A. Kennedy, Bray. M. Du, E. D. Bigler, P. B. Petersen, W. Mc Mahon, et al. 2007 A retrospective fetal ultrasound study of brain size in autism. Biol Psychiatry, 62 10481055
62 - R. A. Hoekstra, M. Bartels, C. J. H. Verweij, D. I. Boomsma, 2007 Heritability of autistic traits in the general population. Arch Pediatr Adolesc Med, 161 372377
63 - S. Ijichi, N. Ijichi, 2004 The prenatal autistic imprinting hypothesis: developmental maladaptation to the environmental changes between womb and the social world. Med Hypotheses, 62 188194
64 - S. Ijichi, N. Ijichi, 2007 Computerized lifelong mentoring support using robot for autistic individuals. Med Hypotheses, 68 493498
65 - S. Ijichi, N. Ijichi, Y. Ijichi, Y. Kawamura, T. Hashiguchi, H. Morioka, 2008 For others: epistasis and the evolutionary survival of an extreme tail of the quantitative distribution of autistic assets. Med Hypotheses, 70 515521
66 - S. Ijichi, N. Ijichi, Y. Ijichi, H. Sameshima, Y. Saeki, W. W. Hall, H. Morioka, 2011 Non-additive interactions between monomorphic and polymorphic loci: a theoretical explanation of the genetic underpinning for complex traits, In: Advances in Medicine and Biology. 13 , Berhardt, L.V., editor, 133-148, Nova Science (New York), https://www.novapublishers.com/catalog/product_info.php?products_id=22873
67 - Y. H. Jiang, T. Sahoo, R. C. Michaelis, D. Bercovich, J. Bressler, C. D. Kashork, et al. 2004 A mixed epigenetic/genetic model for oligogenic inheritance of autism with a limited role for UBE3A. Am J Med Genet, 131 110
68 - M. B. Jones, P. Szatmari, 2002 A risk-factor model of epistatic interaction, focusing on autism. Am J Med Genet, 114 558565
69 - L. B. Jorde, S. J. Hasstedt, E. R. Ritvo, A. Mason-Brothers, B. J. Freeman, C. Pingree, et al. 1991 Complex segregation analysis of autism. Am J Hum Genet, 49 932938
70 - I. Kamp-Becker, J. Smidt, M. Ghahreman, M. Heinzel-Gutenbrunner, K. Becker, H. Remschmidt, 2010 Categorical and dimensional structure of autism spectrum disorders: the nosologic validity of Asperger syndrome. J Autism Dev Disord, 40 921929
71 - M. C. Keller, G. Miller, 2006 Resolving the paradox of common, harmful, heritable mental disorders: which evolutionary genetic models work best? Behav Brain Sci, 29 405452
72 - J. A. Lamb, J. Moore, A. Bailey, A. P. Monaco, 2000 Autism: recent molecular genetic advances. Hum Mol Genet, 9 861868
73 - M. B. Lauritsen, H. Ewald, 2001 The genetics of autism. Acta Psychiatr Scand, 103 41127 .
74 - H. Leonard, N. Nassar, J. Bourke, E. Blair, S. Mulroy, N. de Klerk, et al. 2008 Relation between intrauterine growth and subsequent intellectual disability in a ten-year population cohort of children in Western Australia. Am J Epidemiol, 167 103111
75 - A. M. Lepagnol-Bestel, G. Maussion, B. Boda, A. Cardona, Y. Iwayama, A. L. Delezoide, et al. 2008 SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects. Mol Psychiatry, 13 385397
76 - C. Lord, E. D. Cook, B. L. Leventhal, D. G. Amaral, 2000 Autism spectrum disorders. Neuron, 28 355363
77 - E. Maestrini, A. Paul, A. P. Monaco, A. Bailey, 2000 Identifying autism susceptibility genes. Neuron, 28 1924
78 - R. L. Malmberg, R. Mauricio, 2005 QTL-based evidence for the role of epistasis in evolution. Genet Res, 86 8995
79 - T. A. Manolio, F. S. Collins, N. J. Cox, D. B. Goldstein, L. A. Hindorff, D. J. Hunter, et al. 2009 Finding the missing heritability of complex diseases. Nature, 461 747753
80 - G. F. Marcus, H. Rabagliati, 2006 Genes and domain specificity. Trends Cogn Sci, 10 397398 .
81 - H. Markram, E. Rinaldi, K. Markram, 2007 The intense world syndrome: an alternative hypothesis for autism. Front Neurosci, 1 7796
82 - C. R. Marshall, A. Noor, J. B. Vincent, A. C. Lionel, L. Feuk, J. Skaug, et al. 2008 Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet, 82 477488
83 - G. Maussion, J. Carayol, A. M. Lepagnol-Bestel, F. Tores, Y. Loe-Mie, U. Mibreta, et al. 2008 Convergent evidence identifying MAP/microtubule affinity-regulating kinase 1 (MARK1) as a susceptibility gene for autism. Hum Mol Genet, 17 25412551
84 - J. P. Mc Cleery, E. Allman, L. J. Carver, K. R. Dobkins, 2007 Abnormal magnocellular pathway visual processing in infants at risk for autism. Biol Psychiatry, 62 10071014
85 - C. Mc Govern, M. Sigman, 2005 Continuity and change from early childhood to adolescence in autism. J Child Psychol Psychiatry, 46 401408
86 - N. A. Mitchison, 2000 Polymorphism in regulatory gene sequences. Genome Biol, 2, comment2001.16
87 - R. Moessner, C. R. Marshall, J. S. Sutcliffe, J. Skaug, D. Pinto, J. Vincent, et al. 2007 Contribution of SHANK3 mutations to autism spectrum disorders. Am J Hum Genet, 81 12891297
88 - S. O. Moldin, J. L. R. Rubenstein, S. E. Hyman, 2006 Can autism speak to neuroscience? J Neurosci, 26 68936896
89 - K. V. Morris, 2005 siRNA-mediated transcriptional gene silencing: the potential mechanism and a possible role in the histone code. Cell Mol Life Sci, 62 30573066
90 - R. M. Nesse, G. C. Williams, 1994 Why we get sick: the new science of Darwinian medicine, Vintage Books, 0-67974-674-9 York
91 - M. R. Palmert, J. N. Hirschhorn, 2003 Genetic approaches to stature, pubertal timing, and other complex traits. Mol Genet Metab, 80 110
92 - F. M. Pauler, M. V. Koerner, D. P. Barlow, 2007 Silencing by imprinted noncoding RNAs: is transcription the answer? Trends Genet, 23 284292
93 - A. M. Persico, T. Bourgeron, 2006 Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci, 29 349358
94 - D. Pinto, A. T. Pagnamenta, L. Klei, R. Anney, D. Merico, R. Regan, et al. 2010 Functional impact of global rare copy number variation in autism spectrum disorders. Nature, 466 368372
95 - R. Plomin, M. J. Owen, P. Mc Guffine, 1994 The genetic basis of complex human behaviors. Science, 264 17331739
96 - R. Plomin, S. M. Kosslyn, 2001 Genes, brain and cognition. Nat Neurosci, 4 11531155
97 - R. Plomin, C. M. A. Haworth, O. S. P. Davis, 2009 Common disorders are quantitative traits. Nat Rev Genet, 10 872878
98 - M. B. Posserud, A. J. Lundervold, C. Gillberg, 2006 Autistic features in a total population of 7-9-year-old children assessed by the ASSQ (Autism Spectrum Screening Questionnaire). J Child Psychol Psychiatry, 47 167175
99 - I. Rapin, 1997 Autism. (author reply). N Engl J Med, 337 15561557
100 - I. Rapin, R. Katzman, 1998 Neurobiology of autism. Ann Neurol, 43 714
101 - I. Rapin, 1999 Autism in search of a home in the brain. Neurology, 52 902904
102 - A. M. Reiersen, J. N. Constantino, H. E. Volk, R. D. Todd, 2007 Autistic traits in a population-based ADHD twin sample. J Child Psychol Psychiatry, 48 464472
103 - T. Rinaldi, K. Kulangara, K. Antoniello, H. Markram, 2007 Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci U S A, 104 1350113506
104 - A. Ronald, F. Happé, R. Plomin, 2005 The genetic relationship between individual differences in social and nonsocial behaviours characteristic of autism. Dev Sci, 8 444458
105 - A. Ronald, F. Happé, P. Bolton, L. M. Butcher, T. S. Price, S. Wheelwright, et al. 2006a Genetic heterogeneity between the three components of the autism spectrum: a twin study. J Am Acad Child Adolesc Psychiatry, 45 691699
106 - A. Ronald, F. Happé, T. S. Price, S. Baron-Cohen, R. Plomin, 2006b Phenotypic and genetic overlap between autistic traits at the extremes of the general population. J Am Acad Child Adolesc Psychiatry, 45 12061214
107 - A. Ronald, E. Simonoff, J. Kuntsi, P. Asherson, R. Plomin, 2008 Evidence for overlapping genetic influences on autistic and ADHD behaviours in a community twin sample. J Child Psychol Psychiatry, 49 535542
108 - H. C. Rowe, B. G. Hansen, B. A. Halkier, D. J. Kliebenstein, 2008 Biochemical netwerks and epistasis shape the Arabidopsis theliana metabolome. Plant Cell, 20 11991216
109 - A. Rzhetsky, D. Wajngurt, N. Park, T. Zheng, 2007 Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci U S A, 104 1169411699
110 - S. L. Santangelo, K. Tsatsanis, 2005 What is known about autism: genes, brain, and behavior. Am J Pharmacogenomics, 5 7192
111 - N. C. Schanen, 2006 Epigenetics of autism spectrum disorders. Hum Mol Genet, 15, R138150
112 - K. Scheuffgen, F. Happé, M. Anderson, U. Frith, 2000 High “intelligence,” low “IQ”? speed of processing and measured IQ in children with autism. Dev Psychopathol, 12 8390
113 - C. Schmitz, P. Rezaie, 2008 The neuropathology of autism: where do we stand? Neuropahtol Appl Neurobiol, 34 411
114 - J. Sebat, 2007 Major changes in our DNA lead to major changes in our thinking. Nature Genet, 39(Suppl), S35
115 - J. Sebat, B. Lakshmi, D. Malhotra, J. Troge, C. Lese-Martin, T. Walsh, et al. 2007 Strong association of de novo copy number mutations with autism. Science, 316 445449
116 - D. Simpson, (2003). Autism spectrum disorder is not as certain as implied. BMJ, 326, 986
117 - D. H. Skuse, 2000 Imprinting, the X-chromosoem, and the male brain: explaining sex differences in the liability to autism. Pediatr Res, 47 916
118 - D. H. Skuse, W. P. L. Mandy, J. Scourfield, 2005 Measuring autistic traits: heritability, reliability and validity of the Social and Communication Disorders Checklist. Br J Psychiatry, 187 568572
119 - D. H. Skuse, 2007 Rethinking the nature of genetic vulnerability to autistic spectrum disorders. Trends Genet, 23 387395
120 - Y. J. Sung, G. Dawson, J. Munson, A. Estes, G. D. Schellenberg, E. M. Wijsman, 2005 Genetic investigation of quantitative traits related to autism: use of multivariate polygenic models with ascertainment adjustment. Am J Hum Genet, 76 6881
121 - N. H. Sykes, J. A. Lamb, 2007 Autism: the quest for the genes. Expert Rev Mol Med, 9 115 .
122 - B. J. Tonge, C. Dissanayake, A. V. Brereton, 1994 Autism: fifty years on from Kanner. J Paediatr Child Health, 30 102107
123 - S. Tordjman, P. Ferrari, V. Sulmont, M. Duyme, P. Roubertoux, 1997 Androgenic activity in autism. Am J Psychiatry, 154 16261627
124 - J. van Vliet, N. A. Oates, E. Whitelaw, 2007 Epigenetic mechanisms in the context of complex diseases. Cell Mol Life Sci, 64 15311538
125 - E. Viding, S. J. Blakemore, 2007 Endophenotype approach to developmental psychopathology: implications for autism research. Behav Genet, 37 5160
126 - L. A. Weiss, S. Purcell, S. Waggoner, K. Lawrence, D. Spektor, M. J. Daly, et al. 2007 Identification of EFHC2 as a quantitative trait locus for fear recognition in Turner syndrome. Hum Mol Genet, 16 107113
127 - L. A. Weiss, Y. Shen, J. M. Korn, D. E. Arking, D. T. Miller, R. Fossdal, et al. 2008 Association between microdeletion and microduplication at 1611 2 and autism. N Engl J Med, 358, 667-675
128 - S. A. Willis-Owen, J. Flint, 2006 The genetic basis of emotional behaviour in mice. European J Hum Genet, 14 721728
129 - L. Wing, 1997 The autistic spectrum. Lancet, 350 17611766
130 - J. Yan, G. Oliveira, A. Coutinho, C. Yang, J. Feng, C. Katz, et al. 2005 Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry, 10 329335
131 - J. Yan, K. Noltner, J. Feng, W. Li, R. Schroer, C. Skinner, et al. 2008 Neurecin 1α structural variants associated with autism. Neurosci Lett, 438 368370
132 - X. S. Zhang, W. G. Hill, 2005 Genetic variability under mutation selection balance. Trends Ecol Evol, 20 468470
133 - X. Zhao, A. Leotta, V. Kustanovich, C. Lajonchere, D. H. Geschwind, K. Law, et al. 2007 A unified genetic theory for sporadic and inherited autism. Proc Natl Acad Sci U S A, 104 1283112836